Exhibit 15.2


                   AWARENESS LETTER OF INDEPENDENT ACCOUNTANTS





August 13, 1998



Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549


Re:     ICN Pharmaceuticals, Inc.
        Registrations on Form S-8 (File No. 33-56971) and Form S-3
        (File Nos. 333-10661 and 333-49665)


We are aware  that our  report  dated  July 31,  1998,  on our review of interim
financial  information of ICN Pharmaceuticals,  Inc. for the three and six month
periods  ended June 30, 1998 and included in the Company's  quarterly  report on
Form  10-Q  for the  period  then  ended is  incorporated  by  reference  in the
Registrations  on Form  S-8  (File  No.  33-56971)  and on Form S-3  (File  Nos.
333-10661 and  333-49665).  Pursuant to Rule 436(c) under the  Securities Act of
1933, this report should not be considered a part of the registration  statement
prepared or certified by us within the meaning of Sections 7 and 11 of that Act.

/S/  PRICEWATERHOUSECOOPERS LLP

PricewaterhouseCoopers LLP
Newport Beach, California